Multiple sclerosis with mite antigen-specific IgE

Journal of the Neurological Sciences

Volumn 157, Issue 2, 1998, Pages 138-142

  Kira, Jun Ichi ^a   Kawano, Yuji ^a   Yamasaki, Kenji ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Atopy; HLA; IgE; Mite; Multiple sclerosis

Indexed keywords

HLA ANTIGEN; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E;

ADULT; ARTICLE; ATOPY; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; FEMALE; HUMAN; HYPERIMMUNOGLOBULINEMIA E; IMMUNOGENICITY; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

ADULT; ALLERGENS; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; EPITOPES; FEMALE; GLYCOPROTEINS; HLA-A ANTIGENS; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; MITES; MULTIPLE SCLEROSIS;

EID: 0032493110     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00025-2     Document Type: Article

References (24)

1. Ansari K.A., Yokoyama M.M., Rand A. Circulating IgE, allergy and multiple sclerosis, serum levels of IgE, other immunoglobulins and complement (C3) in patients with multiple sclerosis in exacerbation and other neurologic diseases. Acta Neurol. Scand. 53:1976;39-50.
2. Barsoum A.L., Hoher P.G., Kuwert E.K. Serum immunoglobulin E level and search for myelin basic protein specific IgE antibodies in patients with multiple sclerosis. Med. Microbiol. Immunol. 163:1977;227-232.
3. Beck J., Rondot P., Catinot L.et al. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis; do cytokines trigger off exacerbations? Acta Neurol. Scand. 78:1988;318-323.
4. Birk K., Rudick R. Pregnancy and multiple sclerosis. Arch. Neurol. 43:1986;719-726.
5. Del Prete G.F., De Carli M., D'Elios M.M.et al. Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur. J. Immunol. 23:1993;1445-1449.
6. Gilmore W., Weiner L.P., Correale J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J. Immunol. 158:1997;446-451.
7. Ibrahim M.Z.M., Reder A.T., Lawand R.et al. The mast cells of the multiple sclerosis brain. J. Neuroimmunol. 70:1996;131-138.
8. Imanishi, T., Akaza, T., Kimura, A., 1991. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji, K., Aizawa, M., Sasazuki, T. (Eds.), Proceedings of the 11th International Histocompatibility Workshop and Conference, Veritas Corp., Tokyo, pp. 1067-1074.
9. Kay A.B., Ying S., Varney V.et al. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J. Exp. Med. 173:1991;775-778.
10. Kira J., Yamasaki K., Kawano Y.et al. Acutemyelitis associated with hyperIgEemia and atopic dermatitis. J. Neurol. Sci. 148:1997;199-203.
11. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis, an expanded disability status scale (EDSS). Neurology. 33:1983;1444-1452.
12. Lu C.-Z., Jensen M.A., Arnason B.G.W. Interferon γ- and interluekin-4-secreting cells in multiple sclerosis. J. Neuroimmunol. 46:1993;123-128.
13. Miller S.D., Karpus W.J. The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases. Immunol. Today. 15:1994;356-361.
14. Mosmann T.R., Sad S. The expanding universe of T-cell subsets, Th1, Th2 and more. Immunol. Today. 17:1996;138-146.
15. Panitch H.S., Hirsch R.L., Schindler J.et al. Treatment of multiple sclerosis with γ-interferon, exacerbations associated with activation of the immune system. Neurology. 37:1987;1097-1102.
16. Poser C.M., Paty D.W., Scheinberg L.et al. New diagnostic criteria for multiple sclerosis, guidlines for research protocols. Ann. Neurol. 133:1983;227-231.
17. Rozniecki J.J., Hauser S.L., Stein M.et al. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann. Neurol. 37:1995;63-66.
18. Sadovnick A.D., Eisen K., Hashimoto S.A.et al. Pregnancy and multiple sclerosis, a prospective study. Arch. Neurol. 51:1994;1120-1124.
19. Saeki H., Kuwata S., Nakagawa H.et al. HLA and atopic dermatitis with high serum IgE levels. J. Allergy Clin. Immunol. 94:1994;575-583.
20. Shibasaki H., McDonald W.I., Kuroiwa Y. Racial modifications of clinical picture of multiple sclerosis, comparison between British and Japanese patients. J. Neurol. Sci. 49:1981;253-271.
21. Stenius B., Wide L., Seymour W.M.et al. Clinical significance of specific IgE to common allergens. I. Relationship of specific IgE against Dermatophagoides spp. and grass pollen to skin and nasal tests and history. Clin. Allergy. 1:1971;37-55.
22. Toms R., Weiner H.L., Johnson D. Identification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains. J. Neuroimmunol. 30:1990;169-177.
23. Wekerle H., Kojima K., Lannes-Vieira J.et al. Animal models. Ann. Neurol. 36:1994;S47-S53.
24. Woolf B. On estimating the relation between blood group and disease. Ann. Hum. Genet. 19:1955;251-253.